Molecular basis of phosphorylation-induced activation of the NADPH oxidase

Cell

Volumn 113, Issue 3, 2003, Pages 343-355

  Groemping, Yvonne ^a   Lapouge, Karine ^a,b   Smerdon, Stephen J ^a   Rittinger, Katrin ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME; PROTEIN; PROTEIN GP91; PROTEIN P22; PROTEIN P40; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CYTOPLASM; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME SUBUNIT; FLAVOCYTOCHROME; HOST RESISTANCE; INFECTION; MEMBRANE BINDING; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; STRUCTURE ANALYSIS; X RAY ANALYSIS;

EID: 0037722978     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00314-3     Document Type: Article

References (53)

1. Ago T., Nunoi H., Ito T., Sumimoto H. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J. Biol. Chem. 274:1999;33644-33653.
2. Babior B.M. NADPH oxidase. an update Blood. 93:1999;1464-1476.
3. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 109:2000;33-44.
4. Benard V., Bokoch G.M., Diebold B.A. Potential drug targets. small GTPases that regulate leukocyte function Trends Pharmacol. Sci. 20:1999;365-370.
5. Carson M. Ribbons 2.0. J. Appl. Crystallogr. 24:1991;958-961.
6. CCP4 The CCP4 (Collaborative Computational Project 4) suite. programs for protein crystallography Acta.Crystallogr. D50:1994;760-763.
7. Dalgarno D.C., Botfield M.C., Rickles R.J. SH3 domains and drug design. ligands, structure, and biological function Biopolymers. 43:1997;383-400.
8. de Mendez I., Homayounpour N., Leto T.L. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol. Cell. Biol. 17:1997;2177-2185.
9. Dinauer M.C., Pierce E.A., Erickson R.W., Muhlebach T.J., Messner H., Orkin S.H., Seger R.A., Curnutte J.T. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc. Natl. Acad. Sci. USA. 88:1991;11231-11235.
10. el Benna J., Faust L.P., Babior B.M. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J. Biol. Chem. 269:1994;23431-23436.
11. El Benna J., Faust R.P., Johnson J.L., Babior B.M. Phosphorylation of the respiratory burst oxidase subunit p47phox as determined by two-dimensional phosphopeptide mapping. Phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase. J. Biol. Chem. 271:1996;6374-6378.
12. Esnouf R.M. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr. D Biol. Crystallogr. 55:1999;938-940.
13. Faust L.R., el Benna J., Babior B.M., Chanock S.J. The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis. J. Clin. Invest. 96:1995;1499-1505.
14. Finan P., Shimizu Y., Gout I., Hsuan J., Truong O., Butcher C., Bennett P., Waterfield M.D., Kellie S. An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J. Biol. Chem. 269:1994;13752-13755.
15. Fontayne A., Dang P.M., Gougerot-Pocidalo M.A., El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta. effect on binding to p22phox and on NADPH oxidase activation Biochemistry. 41:2002;7743-7750.
16. Hata K., Ito T., Takeshige K., Sumimoto H. Anionic amphiphile-independent activation of the phagocyte NADPH oxidase in a cell-free system by p47phox and p67phox, both in C terminally truncated forms. Implication for regulatory Src homology 3 domain-mediated interactions. J. Biol. Chem. 273:1998;4232-4236.
17. Heyworth P.G., Curnutte J.T., Nauseef W.M., Volpp B.D., Pearson D.W., Rosen H., Clark R.A. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J. Clin. Invest. 87:1991;352-356.
18. Hiroaki H., Ago T., Ito T., Sumimoto H., Kohda D. Solution structure of the PX domain, a target of the SH3 domain. Nat. Struct. Biol. 8:2001;526-530.
19. Huang J., Kleinberg M.E. Activation of the phagocyte NADPH oxidase protein p47(phox). Phosphorylation controls SH. 3(domain-dependent binding to p22(phox). J. Biol. Chem. 274):1999;19731-19737.
20. Inanami O., Johnson J.L., McAdara J.K., Benna J.E., Faust L.R., Newburger P.E., Babior B.M. Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J. Biol. Chem. 273:1998;9539-9543.
21. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard A. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
22. Kami K., Takeya R., Sumimoto H., Kohda D. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p. EMBO J. 21:2002;4268-4276.
23. Karathanassis D., Stahelin R.V., Bravo J., Perisic O., Pacold C.M., Cho W., Williams R.L. Binding of the PX domain of p47phox to phosphatidylinositol 3,4-biphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J. 21:2002;5057-5068.
24. Kishan K.V., Scita G., Wong W.T., Di Fiore P.P., Newcomer M.E. The SH3 domain of Eps8 exists as a novel intertwined dimer. Nat. Struct. Biol. 4:1997;739-743.
25. Kuriyan J., Cowburn D. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26:1997;259-288.
26. Lambeth D.J. Regulation of the phagocyte respiratory burst oxidase by protein interactions. J. Biochem Mol Biol. 33:2000;427-439.
27. phox J. Biol. Chem. 277:2002;10121-10128.
28. Lee C.H., Saksela K., Mirza U.A., Chait B.T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
29. Leto T.L., Adams A.G., de Mendez I. Assembly of the phagocyte NADPH oxidase. binding of Src homology 3 domains to proline-rich targets Proc. Natl. Acad. Sci. USA. 91:1994;10650-10654.
30. Leusen J.H., Bolscher B.G., Hilarius P.M., Weening R.S., Kaulfersch W., Seger R.A., Roos D., Verhoeven A.J. 156Pro→Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J. Exp. Med. 180:1994;2329-2334.
31. Leusen J.H.W., Verhoeven A.J., Roos D. Interactions between the components of the human NADPH oxidase. a review about the intrigues in the phox family Front. Biosci. 1:1996;d72-d90.
32. Lim W.A. Reading between the lines. SH3 recognition of an intact protein Structure. 4:1996;657-659.
33. Mayer B.J. SH3 domains. complexity in moderation J. Cell Sci. 114:2001;1253-1263.
34. Musacchio A., Saraste M., Wilmanns M. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat. Struct. Biol. 1:1994;546-551.
35. Nauseef W.M. The NADPH-dependent oxidase of phagocytes. Proc. Assoc. Am. Physicians. 111:1999;373-382.
36. Navaza J., Saludjian P. AMoRe. an automated molecular replacement program package Meth. Enzymol. 277:1997;581-594.
37. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
38. Noack D., Rae J., Cross A.R., Ellis B.A., Newburger P.E., Curnutte J.T., Heyworth P.G. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox. mutations not arising in the NCF-1 pseudogenes Blood. 97:2001;305-311.
39. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Meth. Enzymol. 276:1997;307-326.
40. Park J.W., Hoyal C.R., Benna J.E., Babior B.M. Kinase-dependent activation of the leukocyte NADPH oxidase in a cell-free system. Phosphorylation of membranes and p47(PHOX) during oxidase activation. J. Biol. Chem. 272:1997;11035-11043.
41. Perrakis A., Harkiolaki M., Wilson K.S., Lamzin V.S. ARP/wARP and molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 57:2001;1445-1450.
42. Prehoda K.E., Lim W.A. The double life of PX domains. Nat. Struct. Biol. 8:2001;570-572.
43. Segal A.W., Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:1993;43-47.
44. Shiose A., Sumimoto H. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J. Biol. Chem. 275:2000;13793-13801.
45. Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:1997;602-609.
46. Sumimoto H., Hata K., Mizuki K., Ito T., Kage Y., Sakaki Y., Fukumaki Y., Nakamura M., Takeshige K. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J. Biol. Chem. 271:1996;22152-22158.
47. Sumimoto H., Kage Y., Nunoi H., Sasaki H., Nose T., Fukumaki Y., Ohno M., Minakami S., Takeshige K. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc. Natl. Acad. Sci. USA. 91:1994;5345-5349.
48. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55:1999;849-861.
49. Wallace A.C., Laskowski R.A., Thornton J.M. Ligplot. a program to generate schematic diagrams of protein-ligand interactions Protein Eng. 8:1995;127-134.
50. Wilson L., Butcher C., Finan P., Kellie S. SH3 domain-mediated interactions involving the phox components of the NADPH oxidase. Inflamm. Res. 46:1997;265-271.
51. Wiseman T., Williston S., Brandts J.F., Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179:1989;131-137.
52. Wu X., Knudsen B., Feller S.M., Zheng J., Sali A., Cowburn D., Hanafusa H., Kuriyan J. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure. 3:1995;215-226.
53. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602.